In a statement on its website [1], accounting software giant Xero announced that from 2 March 2026, its current “revenue share” model with ...

University of Alberta-led research reports that new cases of syphilis dropped in Alberta following the introduction of rapid point-of-care testing and same-day treatment. The research team compared ...

Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Two years after revamping its developer programs and pricing, X is expanding the closed beta of a pay-per-use plan for its API to more developers. The social network is accepting applications from ...

The Adams administration announced Friday it has approved driverless-taxi firm Waymo’s application to test autonomous vehicles in Gotham — but the robotaxis won’t be picking up passengers anytime soon ...

The software testing landscape is undergoing a seismic shift. For years, continuous automation testing (CAT) platforms have been the gold standard for reducing manual testing and ensuring ...

Cybersecurity company Snyk Ltd. today announced the launch of Snyk API & Web, a new dynamic application security testing or DAST solution designed to meet the growing demands of modern and ...

API Hub for Test enables functional, regression, and integration testing as part of end-to-end API lifecycle management. Teams can now generate tests directly from API specifications defined in API ...

API testing firm APIsec has confirmed it secured an exposed internal database containing customer data, which was connected to the internet for several days without a password. The exposed APIsec ...

A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. have landed in the FDA’s crosshairs thanks to quality shortfalls, poor testing standards ...